Moustafa Magdy

• Leading MDS Business of BD in the Middle East and North Africa Region.
• Countries: UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, Lebanon, Iraq, Syria, Iran, Cyprus, Malta, Libya, Sudan, Algeria, Morocco, and Tunisia.
• Managing MDS B2B business in MENAT region, including above markets, Saudi Arabia, and Turkey.
• Leading a team of sales and business development managers, distributed geographically and supported by clinical, marketing, and cross-functional teams.
• Managing a group of distributors and channel partners across the MENAT region.

• Leading the Medication Delivery Solutions (MDS) business in BD in LENA (LEVANT, Egypt, and North Africa), and based in the newly established regional office in Egypt.
• Managing LENA's 12 markets with a network of 20 distributors.
• Managing MDS portfolio of medical devices and supplies, ranging from conventional needles and syringes to highly specialized catheters and placement devices, with advanced technology.

• Leading the re-launch of Allergan eyecare and Specialty care business units in the Egypt market after two years of discontinuation.
• Building the new team of Eyecare and Specialty in Egypt and ensuring the adoption of proper organizational culture and values.
• Managing a team of sales, marketing, and market access professionals towards the achievement of our organizational goals.
• Full responsibility for P&L management, profitability, and business unit LRP.
• Liaising with distributors for stock management and To Market Sales.
• Leading the launch of new products in the ophthalmology market (Ozurdex).
• Ensuring the access of focus products in the strategic business sectors in Egypt.
• Leading the team through the integration process with AbbVie after the acquisition, starting May 2020.

Awards:

• AbbVie President Award, 2020.

• Leading the re-launch of Allergan eyecare and Specialty care business units in the Egypt market.
• Building the new team of Eyecare and Specialty in Egypt and ensuring the adoption of proper organizational culture and values.
• Managing a team of sales, marketing, and market access professionals.
• Full responsibility for P&L management, profitability, and business unit LRP.
• Leading the launch of new products in ophthalmology.

• Managing Allergan Specialty Care business in the MENA region. Specialty portfolio includes Botox Therapeutics and Allergan's legacy GI portfolio.
• Developing the regional marketing and medical education strategy in line with International AMI objectives.
• Responsible for the execution of regional marketing and AMI activities.
• Supporting the in-country execution with local marketing and sales teams.
• Regional point of contact between international strategic marketing and MENA region.
• Member of IMEA Leadership Team, the Specialty Care International Marketing Board, and the International PSS core team within Allergan.

Awards:

• Allergan International Marketer of the Year Award, TMEA 2016.
• Allergan International Growth Powerhouse Award, 2017.

• Joined to launch Actavis generic business and marketing department in the Saudi market.
• Prepared the launch plan for two branded generic products, Ogliton and Actamone, and launched the first within three months of employment before integration with Allergan.

• Managed a diversified portfolio of branded generics that included Rapidus (Diclofenac Potassium), Triaxone (Ceftriaxone), and Claritt (Clarithromycin).
• Launched the first once daily muscle relaxant in the Saudi market (Prolax ER), September 2013.

Accomplishments:

• Rapidus growth from rank No. 7 in 2010 to rank No. 2 oral NSAIDs in 2013.
• In 2014, Rapidus and Triaxone were ranked in the Saudi top 50 products list.

• Betadine antiseptic range in the Saudi and Egypt markets.
• Co-marketing project with SPIMACO in Saudi, including Hymox (Amoxicillin) and Mafepain (Mefenamic acid).
• Prioderm Lotion in Egypt.

• Betadine antiseptic range in the Saudi and Egypt markets.
• Co-marketing project with SPIMACO in Saudi, including Hymox (Amoxicillin) and Mafepain (Mefenamic acid).
• Prioderm Lotion in Egypt.
• Interim management of co-marketing project with Sanofi, including the following brands: Flagyl, Daonil and Biprofenid.